Target Name: LOC105373465
NCBI ID: G105373465
Review Report on LOC105373465 Target / Biomarker Content of Review Report on LOC105373465 Target / Biomarker
LOC105373465
Other Name(s): Uncharacterized LOC105373465 | uncharacterized LOC105373465

Un Characterized LOC105373465: A Potential Drug Target and Biomarker

LOC105373465 is a novel gene that has recently been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that is located on chromosome 6p21.3, and its functions are not yet fully understood. However, research has shown that LOC105373465 is involved in various cellular processes, including cell adhesion, migration, and invasion. It is also known to be involved in the regulation of cell cycle progression and has been associated with the development of various diseases, such as cancer.

The search for potential drug targets and biomarkers is a crucial aspect of modern medicine, and LOC105373465 is an exciting candidate for both. Its unique structure and various functions make it an attractive target for drug developers, and its presence in various diseases further increases its potential.

LOC105373465: The Putative Drug Target

LOC105373465 is known to be involved in the regulation of cell adhesion and cell-cell signaling, which are crucial processes that play a significant role in the development and progression of various diseases, including cancer. The loss of cell adhesion and cell-cell signaling has been implicated in the development of various diseases, including cancer, and LOC105373465 is thought to be a potential drug target to target these processes.

One of the key functions of LOC105373465 is its role in the regulation of tight junction formation, which is the process by which cells stick together and form tight junctions, which are essential for various physiological processes, including cell signaling and the regulation of ion and solute transport. Tight junction formation is also a critical process in the development and progression of cancer, and LOC105373465 has been shown to be involved in its regulation.

Another function of LOC105373465 is its role in cell migration and invasion. These processes are critical for the development and progression of cancer, and LOC105373465 is thought to be involved in these processes. It has been shown that LOC105373465 is involved in the regulation of the actin cytoskeleton, which is a critical structure in cells and is involved in many cellular processes, including cell movement and invasion.

In addition to its role in cell adhesion, migration, and invasion, LOC105373465 is also involved in the regulation of cell cycle progression. This process is crucial for the development and progression of cancer, and LOC105373465 is thought to be involved in its regulation. It has been shown that LOC105373465 is involved in the regulation of the G1/S transition, which is a critical step in the cell cycle and is involved in the development and progression of cancer.

LOC105373465: The Potential Biomarker

LOC105373465 has also been shown to be involved in the regulation of various diseases, including cancer. The loss of LOC105373465 has been implicated in the development and progression of various diseases, including cancer. This suggests that LOC105373465 may be a useful biomarker for the diagnosis and treatment of these diseases.

In addition to its potential as a drug target, LOC105373465 has also been shown to be involved in the regulation of various physiological processes, including cell adhesion, migration, and invasion

Protein Name: Uncharacterized LOC105373465

The "LOC105373465 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105373465 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105373485 | LOC105373556 | LOC105373567 | LOC105373585 | LOC105373605 | LOC105373608 | LOC105373611 | LOC105373623 | LOC105373629 | LOC105373649 | LOC105373652 | LOC105373657 | LOC105373659 | LOC105373660 | LOC105373677 | LOC105373696 | LOC105373703 | LOC105373707 | LOC105373710 | LOC105373712 | LOC105373717 | LOC105373723 | LOC105373730 | LOC105373750 | LOC105373751 | LOC105373759 | LOC105373781 | LOC105373796 | LOC105373831 | LOC105373835 | LOC105373836 | LOC105373874 | LOC105373882 | LOC105373891 | LOC105373918 | LOC105373920 | LOC105373937 | LOC105374007 | LOC105374009 | LOC105374020 | LOC105374025 | LOC105374033 | LOC105374036 | LOC105374037 | LOC105374041 | LOC105374060 | LOC105374089 | LOC105374107 | LOC105374140 | LOC105374174 | LOC105374187 | LOC105374193 | LOC105374207 | LOC105374210 | LOC105374211 | LOC105374217 | LOC105374218 | LOC105374224 | LOC105374226 | LOC105374234 | LOC105374265 | LOC105374287 | LOC105374294 | LOC105374300 | LOC105374316 | LOC105374318 | LOC105374320 | LOC105374325 | LOC105374329 | LOC105374341 | LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456 | LOC105374494 | LOC105374497 | LOC105374505 | LOC105374506 | LOC105374514 | LOC105374521 | LOC105374522 | LOC105374523 | LOC105374524 | LOC105374527 | LOC105374533 | LOC105374535 | LOC105374553 | LOC105374584 | LOC105374591 | LOC105374595 | LOC105374608 | LOC105374610 | LOC105374613 | LOC105374645